Detalhe da pesquisa
1.
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.
Proc Natl Acad Sci U S A
; 117(1): 292-299, 2020 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31879340
2.
Container Closure and Delivery Considerations for Intravitreal Drug Administration.
AAPS PharmSciTech
; 22(3): 100, 2021 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33709236
3.
Intracellular delivery of the reactive oxygen species generating agent D-penicillamine upon conjugation to poly-L-glutamic acid.
Mol Pharm
; 7(3): 854-62, 2010 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-20349949
4.
Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
Bioconjug Chem
; 19(7): 1382-8, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-18570451
5.
Cross-linked guar gum hydrogel discs for colon-specific delivery of ibuprofen: formulation and in vitro evaluation.
Drug Deliv
; 13(2): 139-42, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-16423802
6.
Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.
Acta Pharm
; 55(3): 277-85, 2005 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16375838
7.
Polymer-Drug Conjugates for Anticancer Drug Delivery.
Crit Rev Ther Drug Carrier Syst
; 32(3): 215-45, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26080809
8.
D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms.
Cancer Lett
; 337(1): 8-21, 2013 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-23727371
9.
Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy.
J Control Release
; 158(2): 215-23, 2012 Mar 10.
Artigo
Inglês
| MEDLINE | ID: mdl-22063001
10.
Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responses.
Eur J Pharm Biopharm
; 80(2): 315-22, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22068049
11.
In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain.
J Control Release
; 158(1): 63-71, 2012 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-22037106
12.
Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
Drug Dev Ind Pharm
; 31(4-5): 367-74, 2005 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16093202